Arvee Laboratories India Ltd (ARVEE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Arvee Laboratories India Ltd on NSE and BSE, with an AI summary of each filing.
Arvee Laboratories (India) Limited has informed the Exchange regarding Resignation of Mr Saurin Ajitbhai Gandhi as Non- Executive Director of the company w.e.f. November 03, 2026.
Change in Management · 04 Nov 2026, 1:37 am
Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 04 Nov 2026, 12:29 am
Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,493 (+622.4% YoY | +44.7% QoQ) ■ EBITDA: 343 (+2592.3% YoY | +37.4% QoQ) ■ EBITDA Margin (%): 13.8 (+1007 bps YoY | -73 bps QoQ) ■ PAT: 256 (+25207.9% YoY | +50.9% QoQ) ■ EPS (INR): 2.32 (+23100.0% YoY | +50.6% QoQ)
Arvee Laboratories (India) Limited has informed the Exchange about Delay/default in the payment of fines/penalties/dues etc. to authority
Others (Uncategorized) · 15 Oct 2026, 11:35 pm
NSE Levies Rs. 10,000 Fine on Arvee Laboratories for LODR Non-Compliance Arvee Laboratories (India) Limited received a notice from the National Stock Exchange dated 14th Oct'26 imposing a fine of Rs. 10,000 plus 18% GST (totaling Rs. 11,800) for non-compliance with Regulation 44(3) of SEBI LODR Regulations for the month ended 30th Sep'26. The company clarified that the voting results PDF was submitted on 30th Sep'26 and the delay in XBRL filing was an inadvertent oversight. The fine has no material impact on the company's financial or operational activities.
ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Arvee Laboratories Schedules Board Meeting on 3rd Nov'26 for Q2 Financial Results Arvee Laboratories (India) Limited has notified the exchange that a meeting of its Board of Directors is scheduled for 3rd Nov'26. The primary agenda is to inter-alia consider and approve the company's unaudited financial results for the quarterly period ended Sep'26.
ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 03 Nov 2026, 5:30 am
Arvee Laboratories Schedules Board Meeting on 3rd Nov'26 to Consider Q2 Results Arvee Laboratories (India) Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26. The board will inter-alia consider, review, and approve the company's standalone unaudited financial results for the quarter and half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 03 Nov 2026, 5:30 am
Arvee Laboratories to Consider Unaudited Financial Results on 3rd Nov'26 Arvee Laboratories (India) Limited has scheduled a Board of Directors meeting on Tuesday, 3rd Nov'26, to consider and approve the standalone unaudited financial results for the period ended 30th Sep'26, among other matters. Pursuant to the company's Code of Conduct for Insider Trading, the trading window has been closed effective 1st Oct'26 and will remain shut until two working days after the declaration of the financial results.
Arvee Laboratories (India) Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 01 Oct 2026, 2:10 am
Proceedings of Annual General Meeting held today that is 29th September, 2026
Annual General Meeting · 29 Sept 2026, 10:13 pm
Arvee Laboratories (India) Limited has informed the Exchange regarding Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2026.
Change in Management · 09 Sept 2026, 10:59 pm
Arvee Laboratories Announces Resignation of Company Secretary Raina Singh Arvee Laboratories (India) Limited disclosed that Mrs. Raina Singh has resigned from her role as Company Secretary and Compliance Officer (Key Managerial Personnel), effective from the close of business hours on 9th Sep'26. According to her resignation letter, she stepped down to pursue an alternate career opportunity outside the organization. The company confirmed there are no other material reasons for her cessation.
Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Outcome · 07 Aug 2026, 11:29 pm
Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 1,723 (+130.3% YoY | +59.4% QoQ) ■ EBITDA: 250 (+627.8% YoY | +126.3% QoQ) ■ EBITDA Margin (%): 14.5 (+990 bps YoY | +428 bps QoQ) ■ PAT: 169 (+901.8% YoY | +225.7% QoQ) ■ EPS (INR): 1.54 (+926.7% YoY | +227.7% QoQ) Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) Segmental Performance Textile Chemical Segment (Films & Fibre) ■ Revenue: 231 ■ EBIT: 30.0 ■ EBIT Margin (%): 13.0 Non-textile Segment ■ Revenue: 1,510 ■ EBIT: 205 ■ EBIT Margin (%): 13.6
ARVEE LABORATORIES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2026 and Scheme of arrangement/Other business.
Intimation · 07 Aug 2026, 5:30 am
Arvee Laboratories Board Meeting to Approve Q1FY27 Results on 07-Aug'26 Arvee Laboratories (India) Ltd announced its Board of Directors will meet on 07-Aug'26. The agenda includes the consideration and approval of the unaudited financial results for the quarter ending Jun'26. Additionally, the board will discuss a potential Scheme of Arrangement and other business matters.
Arvee Laboratories (India) Limited has informed the Exchange regarding Corrigendum to Other
Others (Uncategorized) · 04 Aug 2026, 7:42 pm
Arvee Laboratories Issues Corrigendum on Trading Window Closure Date Arvee Laboratories issued a corrigendum on 03 Aug '26 to correct a typographical error in its letter dated 31 Jul '26. The company clarified that the effective date for the trading window closure is 01 Jul '26, not 01 Apr '26 as previously stated. This correction amends the start date of the insider trading restriction period.
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
Intimation · 29 Jun 2026, 5:30 am
Arvee Laboratories Board to Consider Q1FY27 Results and Textile Chemicals Demerger Arvee Laboratories has scheduled a Board Meeting for 7th Aug'26 to approve standalone unaudited financial results for the quarter ending 30th Jun'26. The board will also consider a significant proposal for the demerger of its Textile Chemicals business. The trading window for insiders has been closed since 1st Apr'26 and will reopen 48 hours after the results are declared. This potential corporate restructuring via a demerger is a key event for shareholders alongside the quarterly earnings announcement.